SPRO
Spero Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.58
-0.01 ▼ -0.39%
🌙 3월 13일 6:05 PM ET (한국 3/14 07:05)
$2.57
-0.01 ▼ -0.39%
| Index | - | P/E | - | EPS (ttm) | -0.79 | Insider Own | 27.64% | Shs Outstand | 0.06B | Perf Week | 12.17% |
| Market Cap | 0.15B | Forward P/E | 3.85 | EPS next Y | 770% | Insider Trans | -1.34% | Shs Float | 0.04B | Perf Month | 8.86% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | - | Inst Own | 15.67% | Short Float | 1.41% | Perf Quarter | 10.73% |
| Income | -0.04B | P/S | 4.96 | EPS this Y | 92.13% | Inst Trans | 1.24% | Short Ratio | 1.93 | Perf Half Y | 32.31% |
| Sales | 0.03B | P/B | 5.48 | EPS next 5Y | - | ROA | -46.31% | Short Interest | 0.57M | Perf YTD | 10.73% |
| Book/sh | 0.47 | P/C | 2.99 | EPS past 3/5Y | 24.13% 17.67% | ROE | -95.29% | 52W High | -19.88% ($3.22) | Perf Year | 231.41% |
| Cash/sh | 0.86 | P/FCF | - | Sales past 3/5Y | 107.42% 8.59% | ROIC | -156.86% | 52W Low | 410.69% ($0.51) | Perf 3Y | 79.17% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -1076.54% | Gross Margin | - | Volatility(W/M) | 6.02% 4.61% | Perf 5Y | -84.59% |
| Dividend TTM | - | EV/Sales | 3.41 | Sales Y/Y TTM | -67.38% | Oper. Margin | -192.13% | ATR (14) | 0.11 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.83 | EPS Q/Q | 58.59% | Profit Margin | -149.52% | RSI (14) | 69.3 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.83 | Sales Q/Q | -61.02% | SMA20 | 10.66% ($2.33) | Beta | 1.45 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 11000000 | SMA50 | 9.12% ($2.36) | Rel Volume | 0.67 | Prev Close | $2.59 |
| Employees | 32 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 48% - | SMA200 | 10.12% ($2.34) | Avg Volume(3M) | 0.30M | Price | $2.58 |
| IPO | 2017/11/2 | Option/Short | Yes/Yes | Trades | 1193 | Volume | 200,360 | Change | -0.39% |
뉴스 로딩 중...